Balanced news tone
News Sentiment
TTX sentiment intelligence
Tetratherix Limited news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Weighted score
53
Balanced news tone
18 relevant articles
News tone and price action are not far from neutral.
91/100 classification confidence.
directly relevant articles
high-authority source matches
-1.3% over one week, -14.7% over four weeks, trend active, and materially above fair value.
Tetratherix (ASX:TTX) Seeks Quotation of Shares as Escrow Period Ends
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Primary event
Market update
91/100 classification
One-week reaction
-1.3%
Price digesting
Trend fit
Trend active
-14.7% over four weeks
Fair value
35.8%
Materially above fair value
Sentiment Mix
Positive, neutral, negative
Positive
3
Neutral
15
Negative
0
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
Above 50
Neutral zone
Below 50
News Tape
Relevant headlines
Kalkine
Direct company coverage
Tetratherix (ASX:TTX) Seeks Quotation of Shares as Escrow Period Ends
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 19 Jun 2026 03:13
- Source
- Kalkine
Kalkine
Direct company coverage
Kalkine Healthcare Focus: Why Is Tetratherix (ASX:TTX) Among Today's Top Healthcare Gainers?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 12 Jun 2026 07:00
- Source
- Kalkine
Kalkine
Direct company coverage
Kalkine Market Focus: TetraTherix Limited (ASX:TTX) Slides as Biotech Shares Face Selling Pressure?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 11 Jun 2026 07:00
- Source
- Kalkine
Moomoo
Direct company coverage
Tetratherix Target Price Raised 4.5% to A$7.15/Share by Morgans>TTX.AU
- Tone
- Neutral 50/100
- Event
- Analyst action
- Published
- 10 Jun 2026 07:00
- Source
- Moomoo
TipRanks
Direct company coverage
Tetratherix launches A$2m share purchase plan for existing investors
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 03 Jun 2026 07:00
- Source
- TipRanks
TipRanks
Direct company coverage
Tetratherix Confirms Compliance After $6.00 Institutional Share Placement
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 03 Jun 2026 07:00
- Source
- TipRanks
grafa.com
Direct company coverage
Tetratherix secures $17M for commercialisation push
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 27 May 2026 07:00
- Source
- grafa.com
Moomoo
Direct company coverage
Market Chatter: Tetratherix Seeks to Raise Around AU$15 Million Via Equity Raise, AFR Says
- Tone
- Positive 82/100
- Event
- Market update
- Published
- 25 May 2026 07:00
- Source
- Moomoo
thebull.com.au
Direct company coverage
Tetratherix Shares Hit New High as Price Doubles Since IPO
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 21 May 2026 07:00
- Source
- thebull.com.au
Business News Australia
Direct company coverage
Newly listed biotech Tetratherix secures global distribution deal with US giant Henry Schein
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 19 Jan 2026 08:00
- Source
- Business News Australia
Stocks Down Under
Direct company coverage
Tetratherix Hits the ASX: What Investors Need to Know About This Fresh Life Sciences Listing
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 01 Jul 2025 07:00
- Source
- Stocks Down Under
Rask Media
Direct company coverage
Tetratherix (TTX), Australia’s own ‘medical Lego’
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 01 Jul 2025 07:00
- Source
- Rask Media
intelligentinvestor.com.au
Direct company coverage
Tetratherix Limited (ASX: TTX) - Share Price
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 01 Jul 2025 05:00
- Source
- intelligentinvestor.com.au
AFR
Direct company coverage
Tetratherix jumps on debut, capping strong week of ASX listings”
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 30 Jun 2025 07:00
- Source
- AFR
Stockhead
Direct company coverage
Health Check: Tetratherix breaks biotech IPO drought with 13pc gain on debut
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 30 Jun 2025 07:00
- Source
- Stockhead
BioWorld News
Direct company coverage
Tetratherix lists on ASX in $25M IPO
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 30 Jun 2025 07:00
- Source
- BioWorld News
Biotech Dispatch
Direct company coverage
Tetratherix lists on the ASX following successful IPO
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 30 Jun 2025 07:00
- Source
- Biotech Dispatch
Business News Australia
Direct company coverage
Tetratherix launches $25m IPO for regenerative biotech
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 06 Jun 2025 07:00
- Source
- Business News Australia